Heart Disease Journals

Cardiology

sponsor

Your Unread Messages

Hello, Mary O'connor
Manage E-mail  |  Logout
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Badruddin A et al. – When choosing an antiplatelet agent for this purpose, clinicians should take into account cost, side effect profile, medical comorbidity, and patient preference. To prevent recurrent stroke, aspirin alone (50–325 mg/d), a combination of aspirin (25 mg) plus extended–release dipyridamole (200 mg), given twice daily, or clopidogrel (75 mg/d) may be used as initial treatment. Prasugrel, a new thienopyridine derivative, more quickly and consistently inhibits platelets than clopidogrel. In stroke patients, prasugrel may be associated with a higher risk of brain hemorrhage, so it may not be indicated when there is a history of cerebrovascular disease.

Related Articles

Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature
Hypertension Research, 11/13/09    Relevance Score: 81%

Stroke-related dementia: Rates, risk factors and implications for future research
Maturitas, 11/11/09    Relevance Score: 81%

Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy, 10/20/09    Relevance Score: 81%

Ischemic stroke and hyperhomocysteinemia: truth or myth
Acta Neurologica Belgica, 10/21/09    Relevance Score: 80%

Low Ankle-Brachial Index Predicts Cardiovascular Risk After Acute Ischemic Stroke or Transient Ischemic Attack
Stroke, 10/20/09    Relevance Score: 80%

Today in Clinical Pharmacology...keeping you current

Long-Term Risk of Adverse Outcomes and New Malignancies in Patients Treated With Oral Sirolimus for Prevention of Restenosis
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 11/24/09

Correlation of paramedic administration of furosemide with emergency physician diagnosis of congestive heart failure
Journal of Emergency Primary Health Care, 11/24/09

Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 11/24/09

Today in Prevention...keeping you current

Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality
European Heart Journal, 11/24/09

Therapeutic Implications of Diabetes in Cardiovascular Disease
American Journal of Therapeutics, 11/24/09

Understanding Omega-3 Polyunsaturated Fatty Acids
Postgraduate Medicine, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address